Director/PDMR Shareholding
Bioventix plc announced that Chief Executive Officer Peter Harrison and his wife Abigail Harrison purchased a total of 2,130 ordinary shares at 1,849 pence per share on April 8, 2026. Following these purchases, Peter Harrison and persons closely associated with him now beneficially own 306,172 ordinary shares, representing approximately 5.9 per cent. of the company's issued share capital.
Select text to share a quote on X · sign in to keep highlights & notes in your BVXP notes
Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company has been notified that earlier today Peter Harrison, Chief Executive Officer, and his wife Abigail Harrison have purchased ordinary shares of 5 pence each in the Company ("Ordinary Shares") at the quantities and prices set out in the table below.
| Director/PDMR | Position | No of shares purchased | Purchase Price |
|---|---|---|---|
| Peter Harrison | Chief Executive Officer | 1,065 | 1,849 pence |
| Abigail Harrison | PCA of Peter Harrison | 1,065 | 1,849 pence |
Following the Purchase, Peter Harrison, together with his persons closely associated, has a beneficial interest in 306,172 Ordinary Shares, representing approximately 5.9 per cent. of the issued share capital of the Company.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Peter Harrison |
| 2. | Reason for the Notification | |
| a) | Position/status | Chief Executive Officer |
| b) | Initial notification/Amendment | Initial notification |
| a) | Name | Bioventix Plc |
| b) | LEI | 213800225MHX7LZQY108 |
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 5 pence each |
| Identification code | GB00B4QVDF07 | |
| b) | Nature of the transaction | Purchase of Ordinary Shares |
| c) | Price(s) and volume(s) | 1,065 Ordinary Shares 1,849 pence |
| d) | Aggregated information: · Aggregated volume · Price | Single transaction as in 4c) above |
| e) | Date of the transaction | 8 April 2026 |
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Abigail Harrison |
| 2. | Reason for the Notification | |
| a) | Position/status | Wife of and PCA with Peter Harrison, Chief Executive Officer |
| b) | Initial notification/Amendment | Initial notification |
| a) | Name | Bioventix Plc |
| b) | LEI | 213800225MHX7LZQY108 |
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 5 pence each |
| Identification code | GB00B4QVDF07 | |
| b) | Nature of the transaction | Purchase of Ordinary Shares |
| c) | Price(s) and volume(s) | 1,065 Ordinary Shares 1,849 pence |
| d) | Aggregated information: · Aggregated volume · Price | Single transaction as in 4c) above |
| e) | Date of the transaction | 8 April 2026 |
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.